Insider Buy/Sell Ratio for March 2026
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Healthcare
Buys230
Sells2123
Buy $$338.79M
Sell $$11.57B
Ratio1:34.16
% Change vs. Prior
Ratio -84.2%Value +496.4%
Technology
Buys139
Sells2712
Buy $$2.33B
Sell $$3.94B
Ratio1:1.69
% Change vs. Prior
Ratio +1323.0%Value +92.5%
Utilities
Buys17
Sells94
Buy $$973.35K
Sell $$5.38B
Ratio1:5531.88
% Change vs. Prior
Ratio -66.7%Value +275.1%
Energy
Buys100
Sells614
Buy $$26.35M
Sell $$4.26B
Ratio1:161.78
% Change vs. Prior
Ratio -65.4%Value +286.7%
Consumer Defensive
Buys56
Sells302
Buy $$17.21M
Sell $$1.06B
Ratio1:61.48
% Change vs. Prior
Ratio -28.6%Value +63.6%
Industrials
Buys203
Sells861
Buy $$43.98M
Sell $$988.40M
Ratio1:22.47
% Change vs. Prior
Ratio +189.3%Value -74.0%
Financial Services
Buys763
Sells801
Buy $$119.12M
Sell $$818.31M
Ratio1:6.87
% Change vs. Prior
Ratio -14.9%Value -72.5%
Consumer Cyclical
Buys120
Sells613
Buy $$274.92M
Sell $$471.02M
Ratio1:1.71
% Change vs. Prior
Ratio +375.2%Value -53.1%
Basic Materials
Buys68
Sells142
Buy $$56.92M
Sell $$558.41M
Ratio1:9.81
% Change vs. Prior
Ratio -29.7%Value +140.8%
Communication Services
Buys132
Sells296
Buy $$35.49M
Sell $$505.80M
Ratio1:14.25
% Change vs. Prior
Ratio -8.7%Value +67.5%
Real Estate
Buys86
Sells218
Buy $$21.92M
Sell $$114.19M
Ratio1:5.21
% Change vs. Prior
Ratio +106.8%Value -19.6%
By Industry
Medical - Instruments & Supplies
Buys25
Sells57
Buy $$14.98M
Sell $$7.62B
Ratio1:508.28
Independent Power Producers
Buys0
Sells11
Buy $$0.00
Sell $$5.30B
RatioAll Sells
Oil & Gas Exploration & Production
Buys57
Sells173
Buy $$10.23M
Sell $$3.06B
Ratio1:299.62
% Change vs. Prior
Ratio -11.7%Value +709.7%
Hardware, Equipment & Parts
Buys17
Sells304
Buy $$2.01B
Sell $$197.79M
Ratio10.14:1
% Change vs. Prior
Ratio +183024.5%Value +454.0%
Medical - Healthcare Information Services
Buys11
Sells90
Buy $$26.79M
Sell $$1.66B
Ratio1:61.82
Software - Application
Buys49
Sells794
Buy $$276.27M
Sell $$882.25M
Ratio1:3.19
Specialty Retail
Buys29
Sells223
Buy $$140.00M
Sell $$1.01B
Ratio1:7.20
% Change vs. Prior
Ratio +121.6%Value +80.2%
Biotechnology
Buys112
Sells1399
Buy $$136.85M
Sell $$834.27M
Ratio1:6.10
% Change vs. Prior
Ratio -67.9%Value +12.2%
Software - Infrastructure
Buys34
Sells546
Buy $$22.72M
Sell $$882.86M
Ratio1:38.85
% Change vs. Prior
Ratio -36.3%Value +94.8%
Computer Hardware
Buys2
Sells368
Buy $$351.04K
Sell $$793.91M
Ratio1:2261.61
Semiconductors
Buys9
Sells427
Buy $$1.52M
Sell $$744.87M
Ratio1:490.70
% Change vs. Prior
Ratio +1864.9%Value -55.5%
Medical - Diagnostics & Research
Buys14
Sells180
Buy $$9.77M
Sell $$699.40M
Ratio1:71.56
Oil & Gas Refining & Marketing
Buys1
Sells90
Buy $$30.31K
Sell $$440.96M
Ratio1:14548.31
Medical - Distribution
Buys0
Sells18
Buy $$0.00
Sell $$426.55M
RatioAll Sells
Aerospace & Defense
Buys14
Sells309
Buy $$13.82M
Sell $$367.11M
Ratio1:26.57
% Change vs. Prior
Ratio +5677.1%Value -85.9%
Transactions (10813)
WEX Inc. (WEX)
Kimball Jennifer — Chief Accounting Officer
Shares
715
Price
$157.82
Total Value
$112.84K
Shares Held After
6,203
% of Holdings
10.3%
GAP INC (GAP)
Gruber Julie — Chief Legal&Compliance Officer
Shares
74,217
Price
$23.85
Total Value
$1.77M
Shares Held After
53,970
% of Holdings
57.9%
GAP INC (GAP)
Breitbard Mark — President & CEO, Gap Brand
Shares
119,155
Price
$23.80
Total Value
$2.84M
Shares Held After
135,884
% of Holdings
46.7%
GAP INC (GAP)
O'Connell Katrina — Chief Financial Officer
Shares
119,155
Price
$23.80
Total Value
$2.84M
Shares Held After
11,503
% of Holdings
91.2%
GAP INC (GAP)
O'Connell Katrina — Chief Financial Officer
Shares
34,258
Price
$24.00
Total Value
$822.19K
Shares Held After
130,658
% of Holdings
20.8%
AXON ENTERPRISE, INC. (AXON)
Nardini Erika — Director
Shares
198
Price
$506.58
Total Value
$100.30K
Shares Held After
1,946
% of Holdings
9.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.40
Total Value
$255.40K
Shares Held After
499,258
% of Holdings
3.7%
ALPHA PRO TECH LTD (APT)
RITOTA JOHN — Director
Shares
2,260
Price
$4.94
Total Value
$11.16K
Shares Held After
41,355
% of Holdings
5.2%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
22,290
Price
$50.73
Total Value
$1.13M
Shares Held After
17,044
% of Holdings
56.7%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
27,710
Price
$49.95
Total Value
$1.38M
Shares Held After
39,334
% of Holdings
41.3%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
10,172
Price
$73.21
Total Value
$744.66K
Shares Held After
82,660
% of Holdings
11.0%
KinderCare Learning Companies, Inc. (KLC)
Wyatt John T. — Director
Shares
219,118
Price
$1.96
Total Value
$429.47K
Shares Held After
762,834
% of Holdings
28.7%
New Mountain Finance Corp (NMFC)
Weinstein Adam B. — Director
Shares
12,900
Price
$7.61
Total Value
$98.16K
Shares Held After
751,756
% of Holdings
1.7%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
23,928
Price
$62.15
Total Value
$1.49M
Shares Held After
430,330
% of Holdings
5.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
12,673
Price
$62.15
Total Value
$787.63K
Shares Held After
454,258
% of Holdings
2.7%
HERSHEY CO (HSY)
Shares
114
Price
$220.73
Total Value
$25.16K
Shares Held After
2,046,119
% of Holdings
0.0%
HERSHEY CO (HSY)
Shares
10
Price
$219.40
Total Value
$2.19K
Shares Held After
2,046,233
% of Holdings
0.0%
HERSHEY CO (HSY)
Shares
51
Price
$218.65
Total Value
$11.15K
Shares Held After
2,046,243
% of Holdings
0.0%
HERSHEY CO (HSY)
Shares
7,068
Price
$217.51
Total Value
$1.54M
Shares Held After
2,046,294
% of Holdings
0.3%
HERSHEY CO (HSY)
Shares
2,214
Price
$216.74
Total Value
$479.86K
Shares Held After
2,053,362
% of Holdings
0.1%
HERSHEY CO (HSY)
Shares
543
Price
$215.57
Total Value
$117.06K
Shares Held After
2,055,576
% of Holdings
0.0%
indie Semiconductor, Inc. (INDI)
Aoki Ichiro — Director
Shares
50,000
Price
$2.59
Total Value
$129.44K
Shares Held After
100,952
% of Holdings
33.1%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
4,397
Price
$62.15
Total Value
$273.27K
Shares Held After
153,902
% of Holdings
2.8%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
7,636
Price
$62.15
Total Value
$474.58K
Shares Held After
158,299
% of Holdings
4.6%
GLOBAL PARTNERS LP (GLP)
Romaine Mark — Chief Operating Officer
Shares
7,500
Price
$47.39
Total Value
$355.43K
Shares Held After
151,609
% of Holdings
4.7%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
2,916
Price
$62.15
Total Value
$181.23K
Shares Held After
71,573
% of Holdings
3.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
5,626
Price
$62.15
Total Value
$349.66K
Shares Held After
74,489
% of Holdings
7.0%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
4,935
Price
$62.15
Total Value
$306.71K
Shares Held After
87,127
% of Holdings
5.4%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
1,100
Price
$81.40
Total Value
$89.54K
Shares Held After
140,750
% of Holdings
0.8%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
1,546
Price
$80.28
Total Value
$124.11K
Shares Held After
141,850
% of Holdings
1.1%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
460
Price
$78.80
Total Value
$36.25K
Shares Held After
143,396
% of Holdings
0.3%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
4,167
Price
$78.07
Total Value
$325.32K
Shares Held After
143,856
% of Holdings
2.8%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
7,956
Price
$3.39
Total Value
$26.97K
Shares Held After
1,180,318
% of Holdings
0.7%
Limbach Holdings, Inc. (LMB)
Brooks Jayme L. — Chief Financial Officer
Shares
2,637
Price
$77.10
Total Value
$203.33K
Shares Held After
148,023
% of Holdings
1.8%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
530,000
Price
$5.00
Total Value
$2.65M
Shares Held After
0
% of Holdings
100.0%
Lazard, Inc. (LAZ)
Orszag Peter Richard — Director
Shares
2,000
Price
$41.66
Total Value
$83.32K
Shares Held After
210,942
% of Holdings
0.9%
Lazard, Inc. (LAZ)
Orszag Peter Richard — Director
Shares
67,170
Price
$40.73
Total Value
$2.74M
Shares Held After
212,942
% of Holdings
24.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$540.92
Total Value
$43.27K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$540.10
Total Value
$421.28K
Shares Held After
40,593
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,709
Price
$539.40
Total Value
$921.83K
Shares Held After
41,373
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,091
Price
$538.41
Total Value
$587.40K
Shares Held After
43,082
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$537.32
Total Value
$537.32K
Shares Held After
44,173
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$536.26
Total Value
$986.71K
Shares Held After
45,173
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
727
Price
$535.05
Total Value
$388.98K
Shares Held After
47,013
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,076
Price
$534.14
Total Value
$574.74K
Shares Held After
47,740
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
667
Price
$533.16
Total Value
$355.62K
Shares Held After
48,816
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$532.24
Total Value
$211.30K
Shares Held After
49,483
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$531.21
Total Value
$70.65K
Shares Held After
49,880
% of Holdings
0.3%
EverCommerce Inc. (EVCM)
Remer Eric Richard — Director
Shares
16,304
Price
$10.31
Total Value
$168.06K
Shares Held After
2,536,613
% of Holdings
0.6%
Velocity Financial, Inc. (VEL)
Kelly Roland Thomas — Chief Legal Officer and GC
Shares
5,160
Price
$18.06
Total Value
$93.21K
Shares Held After
113,934
% of Holdings
4.3%
Showing 1101–1150 of 10813 transactions (page 23 of 217)